0000899243-22-008826.txt : 20220302 0000899243-22-008826.hdr.sgml : 20220302 20220302211238 ACCESSION NUMBER: 0000899243-22-008826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220226 FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: APPIO THOMAS CENTRAL INDEX KEY: 0001683323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 22706472 MAIL ADDRESS: STREET 1: 400 SOMERSET CORPORATE BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-26 0 0000885590 Bausch Health Companies Inc. BHC 0001683323 APPIO THOMAS 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 0 1 0 0 CEO, Pharma Business Common Shares, No Par Value 2022-02-27 4 M 0 24292 A 341517 D Common Shares, No Par Value 2022-02-27 4 F 0 8782 24.35 D 332735 D Common Shares, No Par Value 2022-02-26 4 F 0 2192 24.35 D 330543 D Common Shares, No Par Value 2022-02-27 4 F 0 2402 24.35 D 328141 D Restricted Share Units 2022-02-27 4 A 0 24292 A 2022-02-27 Common Shares, No Par Value 24292 0 D Restricted Share Units 24.35 2022-02-27 4 M 0 24292 24.35 D 2022-02-27 Common Shares, No Par Value 0 0 D Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. Each PSU converts into Common Shares on a one-for-one basis This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs. This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs"). This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs. /s/ Christina Ackermann, attorney-in-fact 2022-03-02